Zinc VC: Investment Portfolio & Startup News
Zinc VC
To add a bio or update investment portfolio click update information.
Investment Portfolio


Unravel Health raises a £2.5m seed round led by Conduit and Wrightwood for daily at-home saliva hormone readings
Unravel Health develops the Micro Lab, a palm-sized device that reads multiple hormones from saliva samples at home in minutes. The product is built for women who need daily, lab-grade hormone data across life stages from puberty to perimenopause.


SolarSub secures a £1.3m pre-seed round led by Sustainable Ventures to develop passive cooling technology for solar modules
SolarSub is a United Kingdom solar technology company developing passive cooling technology for photovoltaic modules. SolarSub’s technology is designed to reduce module operating temperatures without pumps or moving parts, increasing energy yield and reducing heat-related degradation for solar asset owners and operators.


Anemo Labs raises a £700k pre-seed round led by Zinc and SFC Capital to build electronic nose that detects disease signals in smell
Anemo Labs develops electronic nose hardware paired with AI models that detect and classify disease-related volatile organic compounds in urine. The platform is built for clinicians and individuals who need a non-invasive way to screen for disease, with early diagnostic validation running alongside clinical partners.


Respiro Diagnostics raises a £1m pre-seed round led by Zinc Venture Capital and SFC Capital to develop breath-based liquid biopsy for lung cancer
Respiro Diagnostics has developed a breath-based liquid biopsy platform for the early, non-invasive detection of lung cancer and other diseases of the lung. Its device captures a liquid breath sample in minutes and profiles the DNA, RNA and protein within it, giving clinicians a route to earlier detection and more targeted treatment without invasive tissue biopsies.


Cellestial Health raises £515k pre-seed round led by Zinc VC to develop astrocyte-targeting drugs for Parkinson's
Cellestial Health is developing small molecule drugs that target astrocytes in the brain, aiming to create new treatments for Parkinson’s disease and other neurodegenerative conditions with limited existing options.
- 4(12 months)
- zinc.vc
More venture news
- 16 Nov 2026

AlectoAlecto raises a £15m seed round led by Insight Partners to deliver premium legal services for the mass market
SeedLegal - 11 Nov 2026

TendrilsTendrils lands a £23m seed round led by Benchmark to rebuild a computer chip that handles thousands of tasks at once
SeedDeep Tech - 13 Nov 2026

Pro Climbing LeaguePro Climbing League lands a £3m seed round led by Redrice Ventures to bring professional climbing competitions to cities worldwide
SeedConsumer